Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Gestational Trophoblastic Disease 5 Rhabdomyosarcoma 4 Sarcoma 3 Melanoma 3 Testicular Neoplasms 1 Teratoma, Ovarian 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Rhabdoid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Lymphoma 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Hydatidiform Mole, Invasive 1 Histiocytoma, Malignant Fibrous 1 Dermatofibrosarcoma 1 Choroid Plexus Neoplasms 1 Choriocarcinoma 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

Cyclophosphamide 16 Temozolomide 13 Vincristine 10 Irinotecan 8 Melphalan 7 Doxorubicin 7 Topotecan 6 Granulocyte Colony-Stimulating Factor 6 Busulfan 6 fludarabine 5 cabozantinib 5 Etoposide 5 Drug Therapy 5 liposomal doxorubicin 4 Sirolimus 4 Ifosfamide 4 Filgrastim 4 regorafenib 3 pegfilgrastim 3 irinotecan sucrosofate 3 fludarabine phosphate 3 Zoledronic Acid 3 Radiotherapy 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Gemcitabine 3 Cisplatin 3 Bone Marrow Transplantation 3 Albumin-Bound Paclitaxel 3 pegylated granulocyte colony-stimulating factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Sarcoma, Ewing × Dactinomycin × Clear all

NCT07194044 2026-05-15

METTSEO

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡